Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Extracellular vesicles as a novel diagnostic and research tool for patients with HTN and kidney disease

Extracellular vesicles as a novel diagnostic and research tool for patients with HTN and kidney... Hypertension (HTN) affects one in three adults in the United States and is a major risk factor for cardiovascular disease and kidney failure. There is emerging evidence that more intense blood pressure lowering reduces mortality in patients with kidney disease who are at risk of cardiovascular disease and progression to end-stage renal disease. However, the ideal blood pressure threshold for patients with kidney disease remains a question of debate. Novel tools to more precisely diagnose HTN, tailor treatment, and predict the risk of end-organ damage such as kidney disease are needed. Analysis of circulating and urinary extracellular vesicles (EVs) and their cargo (protein and RNA) has the potential to identify novel noninvasive biomarkers that can also reflect a specific pathological mechanism of different HTN phenotypes. We will discuss the use of extracellular vesicles as markers of HTN severity and explain their profile change with antihypertensive medicine and potential to detect early end-organ damage. However, more studies with enhanced rigor in this field are needed to define the blood pressure threshold to prevent or delay kidney disease progression and decrease cardiovascular risk. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png American Journal of Physiology-Renal Physiology The American Physiological Society

Extracellular vesicles as a novel diagnostic and research tool for patients with HTN and kidney disease

Download PDF
7 pages

Loading next page...
 
/lp/the-american-physiological-society/extracellular-vesicles-as-a-novel-diagnostic-and-research-tool-for-z4THSjsvYe

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
1931-857x
eISSN
1522-1466
DOI
10.1152/ajprenal.00071.2019
Publisher site
See Article on Publisher Site

Abstract

Hypertension (HTN) affects one in three adults in the United States and is a major risk factor for cardiovascular disease and kidney failure. There is emerging evidence that more intense blood pressure lowering reduces mortality in patients with kidney disease who are at risk of cardiovascular disease and progression to end-stage renal disease. However, the ideal blood pressure threshold for patients with kidney disease remains a question of debate. Novel tools to more precisely diagnose HTN, tailor treatment, and predict the risk of end-organ damage such as kidney disease are needed. Analysis of circulating and urinary extracellular vesicles (EVs) and their cargo (protein and RNA) has the potential to identify novel noninvasive biomarkers that can also reflect a specific pathological mechanism of different HTN phenotypes. We will discuss the use of extracellular vesicles as markers of HTN severity and explain their profile change with antihypertensive medicine and potential to detect early end-organ damage. However, more studies with enhanced rigor in this field are needed to define the blood pressure threshold to prevent or delay kidney disease progression and decrease cardiovascular risk.

Journal

American Journal of Physiology-Renal Physiology – The American Physiological Society

Published: Sep 1, 2019

References

  • Omics of blood pressure and hypertension
    Arnett, DK; Claas, SA
  • The implications of blood pressure measurement methods on treatment targets for blood pressure
    Bakris, GL
  • Outcomes of intensive blood pressure lowering in older hypertensive patients
    Bavishi, C; Bangalore, S; Messerli, FH
  • Changes in the US burden of chronic kidney disease from 2002 to 2016: an analysis of the global burden of disease study
    Bowe, B; Xie, Y; Li, T; Mokdad, AH; Xian, H; Yan, Y; Maddukuri, G; Al-Aly, Z
  • Urinary podocyte microparticles identify prealbuminuric diabetic glomerular injury
    Burger, D; Thibodeau, JF; Holterman, CE; Burns, KD; Touyz, RM; Kennedy, CR
  • Extracellular vesicles as biomarkers in cardiovascular disease; chances and risks
    Dickhout, A; Koenen, RR
  • Analytical challenges of extracellular vesicle detection: a comparison of different techniques
    Erdbrügger, U; Lannigan, J
  • Extracellular vesicles in renal diseases: more than novel biomarkers
    Erdbrügger, U; Le, TH
  • Imaging flow cytometry elucidates limitations of microparticle analysis by conventional flow cytometry
    Erdbrügger, U; Rudy, CK; Etter, ME; Dryden, KA; Yeager, M; Klibanov, AL; Lannigan, J
  • Irbesartan administration therapeutically influences circulating endothelial progenitor cell and microparticle mobilization by involvement of pro-inflammatory cytokines
    Georgescu, A; Alexandru, N; Nemecz, M; Titorencu, I; Popov, D
  • Urinary extracellular vesicles of podocyte origin and renal injury in preeclampsia
    Gilani, SI; Anderson, UD; Jayachandran, M; Weissgerber, TL; Zand, L; White, WM; Milic, N; Suarez, MLG; Vallapureddy, RR; Nääv, Å; Erlandsson, L; Lieske, JC; Grande, JP; Nath, KA; Hansson, SR; Garovic, VD
  • Urinary exosome miRNome analysis and its applications to salt sensitivity of blood pressure
    Gildea, JJ; Carlson, JM; Schoeffel, CD; Carey, RM; Felder, RA
  • Optimisation of imaging flow cytometry for the analysis of single extracellular vesicles by using fluorescence-tagged vesicles as biological reference material
    Görgens, A; Bremer, M; Ferrer-Tur, R; Murke, F; Tertel, T; Horn, PA; Thalmann, S; Welsh, JA; Probst, C; Guerin, C; Boulanger, CM; Jones, JC; Hanenberg, H; Erdbrügger, U; Lannigan, J; Ricklefs, FL; El-Andaloussi, S; Giebel, B
  • Increased circulating CD31+/annexin V+ apoptotic microparticles and decreased circulating endothelial progenitor cell levels in hypertensive patients with microalbuminuria
    Huang, PH; Huang, SS; Chen, YH; Lin, CP; Chiang, KH; Chen, JS; Tsai, HY; Lin, FY; Chen, JW; Lin, SJ
  • Endothelial- and immune cell-derived extracellular vesicles in the regulation of cardiovascular health and disease
    Jansen, F; Li, Q; Pfeifer, A; Werner, N
  • KDIGO clinical practice guideline for the management of blood pressure in chronic kidney disease
  • The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease
    Klahr, S; Levey, AS; Beck, GJ; Caggiula, AW; Hunsicker, L; Kusek, JW; Striker, G
  • KDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline
    Kramer, HJ; Townsend, RR; Griffin, K; Flynn, JT; Weiner, DE; Rocco, MV; Choi, MJ; Weir, MR; Chang, TI; Agarwal, R; Beddhu, S
  • Endogenous microRNAs in human microvascular endothelial cells regulate mRNAs encoded by hypertension-related genes
    Kriegel, AJ; Baker, MA; Liu, Y; Liu, P; Cowley, AW; Liang, M
  • BP control and long-term risk of ESRD and mortality
    Ku, E; Gassman, J; Appel, LJ; Smogorzewski, M; Sarnak, MJ; Glidden, DV; Bakris, G; Gutiérrez, OM; Hebert, LA; Ix, JH; Lea, J; Lipkowitz, MS; Norris, K; Ploth, D; Pogue, VA; Rostand, SG; Siew, ED; Sika, M; Tisher, CC; Toto, R; Wright, JT; Wyatt, C; Hsu, CY
  • Elevated urinary podocyte-derived extracellular microvesicles in renovascular hypertensive patients
    Kwon, SH; Woollard, JR; Saad, A; Garovic, VD; Zand, L; Jordan, KL; Textor, SC; Lerman, LO
  • Non-coding RNA in the pathogenesis, progression and treatment of hypertension
    Leimena, C; Qiu, H
  • miRNA profiling of exosomes from spontaneous hypertensive rats using next-generation sequencing
    Liu, X; Yuan, W; Yang, L; Li, J; Cai, J
  • Evolving role of microparticles in the pathophysiology of endothelial dysfunction
    Lovren, F; Verma, S
  • Association between more intensive vs less intensive blood pressure lowering and risk of mortality in chronic kidney disease stages 3 to 5: a systematic review and meta-analysis
    Malhotra, R; Nguyen, HA; Benavente, O; Mete, M; Howard, BV; Mant, J; Odden, MC; Peralta, CA; Cheung, AK; Nadkarni, GN; Coleman, RL; Holman, RR; Zanchetti, A; Peters, R; Beckett, N; Staessen, JA; Ix, JH
  • Platelet microRNAs in hypertensive patients with and without cardiovascular disease
    Marketou, M; Kontaraki, J; Papadakis, J; Kochiadakis, G; Vrentzos, G; Maragkoudakis, S; Fragkiadakis, K; Katsouli, E; Plataki, M; Patrianakos, A; Chlouverakis, G; Papanikolaou, K; Vardas, P; Parthenakis, F
  • Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery
    Merchant, ML; Rood, IM; Deegens, JKJ; Klein, JB
  • Essential hypertension
    Messerli, FH; Williams, B; Ritz, E
  • Aliskiren, a direct renin inhibitor, improves vascular endothelial function in patients on hemodialysis independent of antihypertensive effect approximately a pilot study approximately
    Moriya, H; Kobayashi, S; Ohtake, T; Tutumi, D; Mochida, Y; Ishioka, K; Oka, M; Maesato, K; Hidaka, S; Nomura, S
  • Potential US population impact of the 2017 ACC/AHA high blood pressure guideline
    Muntner, P; Carey, RM; Gidding, S; Jones, DW; Taler, SJ; Wright, JT; Whelton, PK
  • Non-coding RNAs and hypertension-unveiling unexpected mechanisms of hypertension by the dark matter of the genome
    Murakami, K
  • A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension
    Olsen, MH; Angell, SY; Asma, S; Boutouyrie, P; Burger, D; Chirinos, JA; Damasceno, A; Delles, C; Gimenez-Roqueplo, AP; Hering, D; López-Jaramillo, P; Martinez, F; Perkovic, V; Rietzschel, ER; Schillaci, G; Schutte, AE; Scuteri, A; Sharman, JE; Wachtell, K; Wang, JG
  • Plasma exosomes regulate systemic blood pressure in rats
    Otani, K; Yokoya, M; Kodama, T; Hori, K; Matsumoto, K; Okada, M; Yamawaki, H
  • Low levels of microRNA-21 are a marker of reduced arterial stiffness in well-controlled hypertension
    Parthenakis, F; Marketou, M; Kontaraki, J; Patrianakos, A; Nakou, H; Touloupaki, M; Vernardos, M; Kochiadakis, G; Chlouverakis, G; Vardas, P
  • Comparative microRNA profiling in relation to urinary albumin excretion in newly diagnosed hypertensive patients
    Parthenakis, FI; Marketou, ME; Kontaraki, JE; Maragoudakis, F; Maragkoudakis, S; Nakou, H; Roufas, K; Patrianakos, A; Chlouverakis, G; Malliaraki, N; Vardas, PE
  • Urinary exosome miR-146a is a potential marker of albuminuria in essential hypertension
    Perez-Hernandez, J; Olivares, D; Forner, MJ; Ortega, A; Solaz, E; Martinez, F; Chaves, FJ; Redon, J; Cortes, R
  • Extracellular vesicles in renal pathophysiology
    Pomatto, MAC; Gai, C; Bussolati, B; Camussi, G
  • Effects of severe hypertension on endothelial and platelet microparticles
    Preston, RA; Jy, W; Jimenez, JJ; Mauro, LM; Horstman, LL; Valle, M; Aime, G; Ahn, YS
  • Regulation of 11beta-hydroxysteroid dehydrogenase type 2 by microRNA
    Rezaei, M; Andrieu, T; Neuenschwander, S; Bruggmann, R; Mordasini, D; Frey, FJ; Vogt, B; Frey, BM
  • Endothelial microparticles and vascular parameters in subjects with and without arterial hypertension and coronary artery disease
    Sansone, R; Baaken, M; Horn, P; Schuler, D; Westenfeld, R; Amabile, N; Kelm, M; Heiss, C
  • Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines
    Théry, C; Witwer, KW; Aikawa, E; Alcaraz, MJ; Anderson, JD; Andriantsitohaina, R; Antoniou, A; Arab, T; Archer, F; Atkin-Smith, GK
  • Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation
    van der Pol, E; Sturk, A; van Leeuwen, T; Nieuwland, R; Coumans, F; Mobarrez, F; Arkesteijn, G; Wauben, M; Siljander, PR-M; Sánchez-López, V
  • EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research
    Van Deun, J; Mestdagh, P; Agostinis, P; Akay, Ö; Anand, S; Anckaert, J; Martinez, ZA; Baetens, T; Beghein, E; Bertier, L
  • Shedding light on the cell biology of extracellular vesicles
    van Niel, G; D’Angelo, G; Raposo, G
  • Elevated circulating endothelial microparticles and brachial-ankle pulse wave velocity in well-controlled hypertensive patients
    Wang, JM; Su, C; Wang, Y; Huang, YJ; Yang, Z; Chen, L; Wu, F; Xu, SY; Tao, J
  • 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: Executive Summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
    Whelton, PK; Carey, RM; Aronow, WS; Casey, DE; Collins, KJ; Dennison Himmelfarb, C; DePalma, SM; Gidding, S; Jamerson, KA; Jones, DW; MacLaughlin, EJ; Muntner, P; Ovbiagele, B; Smith, SC; Spencer, CC; Stafford, RS; Taler, SJ; Thomas, RJ; Williams, KA; Williamson, JD; Wright, JT
  • 2018 ESC/ESH guidelines for the management of arterial hypertension
    Williams, B; Mancia, G; Spiering, W; Agabiti Rosei, E; Azizi, M; Burnier, M; Clement, DL; Coca, A; de Simone, G; Dominiczak, A; Kahan, T; Mahfoud, F; Redon, J; Ruilope, L; Zanchetti, A; Kerins, M; Kjeldsen, SE; Kreutz, R; Laurent, S; Lip, GYH; McManus, R; Narkiewicz, K; Ruschitzka, F; Schmieder, RE; Shlyakhto, E; Tsioufis, C; Aboyans, V; Desormais, I; Group, ESCSD
  • Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial
    Wright, JT; Bakris, G; Greene, T; Agodoa, LY; Appel, LJ; Charleston, J; Cheek, D; Douglas-Baltimore, JG; Gassman, J; Glassock, R; Hebert, L; Jamerson, K; Lewis, J; Phillips, RA; Toto, RD; Middleton, JP; Rostand, SG
  • A randomized trial of intensive versus standard blood-pressure control
    Wright, JT; Williamson, JD; Whelton, PK; Snyder, JK; Sink, KM; Rocco, MV; Reboussin, DM; Rahman, M; Oparil, S; Lewis, CE; Kimmel, PL; Johnson, KC; Goff, DC; Fine, LJ; Cutler, JA; Cushman, WC; Cheung, AK; Ambrosius, WT
  • Endothelial dysfunction in diabetes and hypertension: role of microRNAs and long non-coding RNAs
    Zhang, HN; Xu, QQ; Thakur, A; Alfred, MO; Chakraborty, M; Ghosh, A; Yu, XB
  • Endothelial microparticles after antihypertensive and lipid-lowering therapy inhibit the adhesion of monocytes to endothelial cells
    Zu, L; Ren, C; Pan, B; Zhou, B; Zhou, E; Niu, C; Wang, X; Zhao, M; Gao, W; Guo, L; Zheng, L